business

Zepbound copycats remain online despite FDA ban - CNBC

Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're still available on some websites.

By:Angelica Peebles
Source:CNBC
Published:
Zepbound copycats remain online despite FDA ban - CNBC
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn't look like much has… [+4931 chars]

Related News